Pharmaceutical News and Articles

Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma

Poor Sleep Endangering The Health of Two-Thirds of Americans

About two-thirds of Americans are getting too little or too much sleep, risking their health, a new study suggests. In fact, people not getting the right amount

U.S. Ends Funding for Thousands of Global Health Programs

The U.S. government has ended funding for some 5,800 global health programs, cutting off critical support for projects that provide vaccines, life-saving medica

Severe Flu Season Raises Concerns About Brain Complications in Kids

As this year s severe flu season rages across the country, federal health officials are investigating a rise in rare but life-threatening brain complications in

Study Explores Effect of Hybrid Closed-Loop Therapy on Diabetic Complications

For young people with type 1 diabetes, hybrid closed-loop insulin delivery does not affect the rate of severe hypoglycemia and is associated with an increased r

Gynecological Disorders Can Increase Risk for Cardiovascular, Cerebrovascular Disease

Nonmalignant gynecological diseases (NMGD) are associated with cardiovascular and or cerebrovascular disease (C CVD), according to a systematic review and meta-

Patients Hospitalized With COVID-19 Face Higher Long-Term Risk for Death, Rehospitalization

Individuals previously hospitalized for COVID-19 have an increased risk for subsequent death or hospitalization for various organ disorders up to 30 months afte

Uptake of Supportive Care Low for Patients With Advanced Cancer

Many patients with advanced cancer receive potentially aggressive care in the last month of life at the expense of supportive care, according to a study publish

U.S. Cancels Ebola Aid in Uganda Despite Elon Musk’s Claims

Hours after billionaire Elon Musk told the president s Cabinet that the U.S. had quickly restored canceled aid to fight Ebola in Uganda, the Trump administratio

FDA Makes Access to Clozapine Easier for Patients With Schizophrenia

The U.S. Food and Drug Administration has removed one hurdle faced by patients with schizophrenia when filling prescriptions for the antipsychotic medication cl